Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • News

    Questions Have Been Raised about Potential Risks from Using Abbott Laboratories’ Novel Coronary Stent

    March 21, 2016

    (Reuters) - U.S. government scientists have raised questions about the potential risks to patients of heart attacks and blood clots from Abbott Laboratories' novel coronary stent that dissolves after it is implanted. Abbott is seeking U.S.

  • 1
    News

    New Clinical Guides Available on Anemia, Congestive Heart Failure

    March 17, 2016

    SHM’s implementation tool kits provide hospitalists the information and tools they need to lead quality improvement projects on specific clinical topics, including two recent releases focused on anemia and congestive heart failure. One third of the world’s population suffers from anemia, and SHM’

  • News

    CRT in Patients with Heart Failure Without LBBB May Harm

    March 4, 2016

    NEW YORK (Reuters Health) - Cardiac resynchronization therapy (CRT) in patients with heart failure (HF) without left bundle branch block (LBBB) may not help and might even harm, according to an international group of investigators. As Dr.

  • News

    Study Shows ICDs Benefit Women in Heart Failure Prevention

    February 4, 2016

    NEW YORK (Reuters Health)—Women with heart failure (HF) derive as much benefit from implantable cardiac defibrillators (ICDs) for primary prevention as men, according to a comparative effectiveness study. "Randomized clinical trials demonstrated that the ICD confers survival benefit to many patie

  • News

    Early Invasive Strategy for Acute Coronary Syndrome May, or May Not, Improve Outcomes

    January 8, 2016

    Clinical question: Does an early invasive strategy for acute coronary syndrome improve short-term outcomes? Bottom line: According to this real-world observational study, an early invasive strategy—coronary angiogram within 72 hours of presentation—is associated with lower risks of short-term car

  • News

    Coronary CT Angiography, Perfusion Imaging Effective for Evaluating Patients With Chest Pain

    November 4, 2015

    Clinical question: When evaluating the intermediate-risk patient with chest pain, should coronary computed tomography angiography (CCTA) be used instead of myocardial perfusion imaging (MPI)? Background: CCTA has been shown in prior randomized controlled trials to save time and money compared to

  • News

    Heart Disease Linked to Loud Noise

    October 30, 2015

    NEW YORK - People with long-term exposure to loud noise at work or in leisure activities may be at increased risk of heart disease, a U.S.

  • News

    Medicare Tests New Quality Measure: Readmission Rates for Heart Failure

    October 6, 2015

    The Centers for Medicare & Medicaid Services (CMS) has wrapped up a test run of a new measure for readmission of heart failure patients as the federal agency tries to educate hospitals and hospitalists before formally including it as a quality metric in fiscal year 2018. The trial concludes O

  • News

    Hospitalists Can Earn CME Credits for Acute Coronary Syndrome Performance Improvement

    October 6, 2015

    Approximately 1.7 million patients are hospitalized for acute coronary syndrome (ACS), and 600,000 die of an acute myocardial infarction. Although ACS is a major cause of morbidity and mortality, a broad range of clinical strategies can affect outcomes if implemented effectively.

  • News

    Coronary Computed Tomography Angiography, Radionuclide Stress Testing Similar for Evaluation of Chest Pain

    October 5, 2015

    Clinical question: Is coronary computed tomography angiography better than stress testing for detecting coronary artery disease? Bottom line: For the evaluation of chest pain in intermediate-risk patients, coronary computed tomography angiography (CCTA) is comparable with myocardial perfusion ima

Previous1 … 73 74 75 76 77 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences